MedPath
HSA Approval

METFORMIN TABLET 250 mg (FILM-COATED)

SIN07751P

METFORMIN TABLET 250 mg (FILM-COATED)

METFORMIN TABLET 250 mg (FILM-COATED)

June 21, 1994

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A10BA02

metformin

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

METFORMIN HCl

250 mg

Metformin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METFORMIN TABLET 250 mg (FILM-COATED) - HSA Approval | MedPath